November 2011
HealthLeaders Magazine;Nov2011, Vol. 14 Issue 11, p11
The article explores the hospital merger and acquisition (M&A) process prevailing in the U.S. healthcare industry today, focusing on the factors driving the consolidations, and the strategies employed in finding a suitable partner. It notes that the first nine months of 2011 has exceeded the 2010 record in terms of total hospitals involved, number of deals, and total value. Cited are several examples of successful mergers including Novant Health, and Lennox Hill Hospital.


Related Articles

  • WHEN LESS MEANS MORE. Becker, Cinda // Modern Healthcare;6/25/2007, Vol. 37 Issue 26, p6 

    The article illustrates the significance of the consolidation strategies between hospitals in the U.S. The disproportionate-share adjustment is an add-on to the inpatient DRG payments, offering a percentage increase in Medicare payments to qualifying hospitals. It reveals that...

  • Mergers and Acquisitions.  // H&HN: Hospitals & Health Networks;Feb2007, Vol. 81 Issue 2, p68 

    The article reports on mergers and acquisitions in the health care industry in the U.S. Mercy Medical Center in Sioux City, Iowa has acquired Oakland Memorial Hospital. Mount Carmel Health System merge with New Albany Surgical Hospital with the goal of creating an orthopedic and neurological...

  • Regional News.  // Modern Healthcare;5/31/2004, Vol. 34 Issue 22, p18 

    Presents regional news briefs related to the U.S. health care industry as of May 2004. Decision of Continuum Health Partners to sell the Singer Division of Beth Israel Medical Center; Definitive agreement signed by LifePoint Hospitals to buy River Parishes Hospital; Job reduction at Health Net.

  • A Mixed Bag: Sorting Out Efficiencies Arguments in Hospital Mergers. OLIVER, LEIGH L.; LEIBENLUFT, ROBERT F. // Antitrust Magazine;Fall2015, Vol. 30 Issue 1, p18 

    The article provides information related to anti-trust issues in hospital mergers in the U.S. It examines how the enforcement agencies and courts evaluate efficiencies asserted in medical care transactions as well as provides detail about the country's health care industry, which reportedly...

  • Dealmaking keeps up heady pace. Evans, Melanie // Modern Healthcare;1/25/2016, Vol. 46 Issue 4, p0019 

    The article highlights business deals in the healthcare industry in the fourth quarter of 2015. Topics discussed include deals by health systems and insurance companies, the record volume of merger and acquisitions such as the acquisition of pharmaceutical company Allergan by Pfizer, and...

  • BUSINESS WATCH. Roszak, Dennis J. // H&HN: Hospitals & Health Networks;Sep2004, Vol. 78 Issue 9, p86 

    Presents business update in the healthcare industry in the U.S. as of September 2004. Value of the acquisition deal between LifePoint Hospitals and Province Healthcare; Information on the acquisition deal between Sylacauga Health Care Authority and Baptist Health System Inc.; Features of a...

  • Talks said in works for transfer of Caritas Christi Health Care.  // Medical Device Daily;9/4/2007, Vol. 11 Issue 168, p5 

    This section presents news briefs about intercompany agreements in the healthcare industry. Archdiocese of Boston is planning to transfer its ailing Caritas Christi Health Care system to Catholic Health Initiatives. HealthCare Partners extended its group purchasing partnership with Premier Alliance.

  • Embracing Nontraditional Models. BETBEZE, PHILIP // HealthLeaders Magazine;Jan/Feb2013, Vol. 16 Issue 1, p30 

    The article focus on the approach employed by healthcare organizations in dealing with the changes in reimbursement patterns and accountability. Most companies practice watchful waiting and engage in traditional consolidation where hospitals acquire another hospitals. However, some leaders take...

  • Provider and pharmacy sector sees lively quarter. Kutscher, Beth // Modern Healthcare;10/20/2014, Vol. 44 Issue 42, p0018 

    The article reports that pharmacies and pharmacy benefit managers in the U.S. closed 13 transactions in the third quarter of 2014 after forging only five deals in the first half of the year. Topics mentioned include the amount of money spent by pharmaceutical and biotechnology firms on...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics